Search research articles
Contact Us
Filters
Showing results (81-90 of 94) with videos related to
Page
of 10
Sort By:
American Journal of Clinical Oncology
|
September 3, 2024
Does the Primary Tumor Site Drive Biology for Patients With Synovial Sarcoma?
Riddhi R Patel, George L Delclos, Stacia M DeSantis, et al.
Rare Tumors
|
August 6, 2024
Clinical characteristics and outcomes of adult alveolar rhabdomyosarcoma patients on first-line systemic therapies: A single-institution cohort
Michael S Nakazawa, J Andrew Livingston, Maria A Zarzour, et al.
Clinical Sarcoma Research
|
January 1, 2013
Extensive adipocytic maturation can be seen in myxoid liposarcomas treated with neoadjuvant doxorubicin and ifosfamide and pre-operative radiation therapy
Wei-Lien Wang, Daniela Katz, Dejka M Araujo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 26, 2011
R1507, a monoclonal antibody to the insulin-like growth factor 1 receptor, in patients with recurrent or refractory Ewing sarcoma family of tumors: results of a phase II Sarcoma Alliance for Research through Collaboration study
Alberto S Pappo, Shreyaskumar R Patel, John Crowley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 16, 2015
Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial
George D Demetri, Margaret von Mehren, Robin L Jones, et al.
Journal of Adolescent and Young Adult Oncology
|
February 1, 2023
Joint Adult and Pediatric Working Group as a Successful Platform to Strengthen Adolescent and Young Adult (AYA) Clinical Trial Collaboration: A Report from the NCTN/SARC AYA Clinical Trials Sarcoma Working Group
Susan L Whiteway, Aaron R Weiss, Safia K Ahmed, et al.
Cancer
|
October 4, 2016
Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor
Scott M Schuetze, Vanessa Bolejack, Edwin Choy, et al.
Molecular Cancer Therapeutics
|
April 1, 2024
Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient Leiomyosarcomas
Michael S Nakazawa, Ian M Silverman, Victoria Rimkunas, et al.
Cancer
|
July 6, 2022
Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort study
Vinod Ravi, Aparna Subramaniam, Jing Zheng, et al.
Journal of Adolescent and Young Adult Oncology
|
September 13, 2021
Identified Enrollment Challenges of Adolescent and Young Adult Patients on the Nonchemotherapy Arm of Children's Oncology Group Study ARST1321
Viswatej Avutu, Aaron R Weiss, Damon R Reed, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 94) with videos related to
Sort By:
Page
of 10
American Journal of Clinical Oncology
|
September 3, 2024
Does the Primary Tumor Site Drive Biology for Patients With Synovial Sarcoma?
Riddhi R Patel, George L Delclos, Stacia M DeSantis, et al.
Rare Tumors
|
August 6, 2024
Clinical characteristics and outcomes of adult alveolar rhabdomyosarcoma patients on first-line systemic therapies: A single-institution cohort
Michael S Nakazawa, J Andrew Livingston, Maria A Zarzour, et al.
Clinical Sarcoma Research
|
January 1, 2013
Extensive adipocytic maturation can be seen in myxoid liposarcomas treated with neoadjuvant doxorubicin and ifosfamide and pre-operative radiation therapy
Wei-Lien Wang, Daniela Katz, Dejka M Araujo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 26, 2011
R1507, a monoclonal antibody to the insulin-like growth factor 1 receptor, in patients with recurrent or refractory Ewing sarcoma family of tumors: results of a phase II Sarcoma Alliance for Research through Collaboration study
Alberto S Pappo, Shreyaskumar R Patel, John Crowley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 16, 2015
Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial
George D Demetri, Margaret von Mehren, Robin L Jones, et al.
Journal of Adolescent and Young Adult Oncology
|
February 1, 2023
Joint Adult and Pediatric Working Group as a Successful Platform to Strengthen Adolescent and Young Adult (AYA) Clinical Trial Collaboration: A Report from the NCTN/SARC AYA Clinical Trials Sarcoma Working Group
Susan L Whiteway, Aaron R Weiss, Safia K Ahmed, et al.
Cancer
|
October 4, 2016
Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor
Scott M Schuetze, Vanessa Bolejack, Edwin Choy, et al.
Molecular Cancer Therapeutics
|
April 1, 2024
Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient Leiomyosarcomas
Michael S Nakazawa, Ian M Silverman, Victoria Rimkunas, et al.
Cancer
|
July 6, 2022
Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort study
Vinod Ravi, Aparna Subramaniam, Jing Zheng, et al.
Journal of Adolescent and Young Adult Oncology
|
September 13, 2021
Identified Enrollment Challenges of Adolescent and Young Adult Patients on the Nonchemotherapy Arm of Children's Oncology Group Study ARST1321
Viswatej Avutu, Aaron R Weiss, Damon R Reed, et al.
Page
of 10